Literature DB >> 13678567

Group A Streptococcal Sepsis.

Dennis L. Stevens1.   

Abstract

The fulminant nature of group A streptococcal sepsis poses impressive challenges from diagnostic and therapeutic perspectives. Most patients are seen early in the course of infection by primary care providers or emergency department physicians and sent home, only to return in 12 to 24 hours with fully developed group A streptococcal sepsis. Early diagnosis is imperative, but the clinician must have a high index of suspicion. Often, the diagnosis is established only after aggressive interventional management has begun. This review emphasizes salient clinical features and provides general recommendations for critical care management.

Entities:  

Year:  2003        PMID: 13678567      PMCID: PMC7101722          DOI: 10.1007/s11908-003-0017-7

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  48 in total

1.  Transmission of Streptococcus pyogenes causing toxic shock-like syndrome among family members and confirmation by DNA macrorestriction analysis.

Authors:  S Ichiyama; K Nakashima; K Shimokata; M Ohta; Y Shimizu; K Ooe; H Igarashi; T Murai
Journal:  J Infect Dis       Date:  1997-03       Impact factor: 5.226

2.  Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.

Authors:  R Kaul; A McGeer; A Norrby-Teglund; M Kotb; B Schwartz; K O'Rourke; J Talbot; D E Low
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

3.  Necrotising fasciitis.

Authors:  J M Yong
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

4.  An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children.

Authors:  F R Cockerill; K L MacDonald; R L Thompson; F Roberson; P C Kohner; J Besser-Wiek; J M Manahan; J M Musser; P M Schlievert; J Talbot; B Frankfort; J M Steckelberg; W R Wilson; M T Osterholm
Journal:  JAMA       Date:  1997-01-01       Impact factor: 56.272

5.  Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.

Authors:  J Zimbelman; A Palmer; J Todd
Journal:  Pediatr Infect Dis J       Date:  1999-12       Impact factor: 2.129

6.  Streptococcal pyrogenic exotoxin A release, distribution, and role in a murine model of fasciitis and multiorgan failure due to Streptococcus pyogenes.

Authors:  S Sriskandan; D Moyes; L K Buttery; T Krausz; T J Evans; J Polak; J Cohen
Journal:  J Infect Dis       Date:  1996-06       Impact factor: 5.226

7.  Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers.

Authors:  J R DiPersio; T M File; D L Stevens; W G Gardner; G Petropoulos; K Dinsa
Journal:  Clin Infect Dis       Date:  1996-03       Impact factor: 9.079

8.  Effect of antibiotics on toxin production and viability of Clostridium perfringens.

Authors:  D L Stevens; K A Maier; J E Mitten
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

9.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group.

Authors:  H D Davies; A McGeer; B Schwartz; K Green; D Cann; A E Simor; D E Low
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

10.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

View more
  10 in total

1.  Platelet activation by Streptococcus pyogenes leads to entrapment in platelet aggregates, from which bacteria subsequently escape.

Authors:  Lisbeth Svensson; Maria Baumgarten; Matthias Mörgelin; Oonagh Shannon
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

2.  Platelet-Dependent Neutrophil Function Is Dysregulated by M Protein from Streptococcus pyogenes.

Authors:  Sinéad M Hurley; Fredrik Kahn; Pontus Nordenfelt; Matthias Mörgelin; Ole E Sørensen; Oonagh Shannon
Journal:  Infect Immun       Date:  2015-06-22       Impact factor: 3.441

3.  The ScpC protease of Streptococcus pyogenes affects the outcome of sepsis in a murine model.

Authors:  Hong Sjölinder; Lena Lövkvist; Laura Plant; Jens Eriksson; Helena Aro; Allison Jones; Ann-Beth Jonsson
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

4.  The secreted esterase of group a streptococcus is important for invasive skin infection and dissemination in mice.

Authors:  Hui Zhu; Mengyao Liu; Paul Sumby; Benfang Lei
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

5.  Targeting Rac1 signaling inhibits streptococcal M1 protein-induced CXC chemokine formation, neutrophil infiltration and lung injury.

Authors:  Songen Zhang; Milladur Rahman; Su Zhang; Lei Song; Heiko Herwald; Henrik Thorlacius
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

6.  Group A Streptococci: A rare and often misdiagnosed cause of spontaneous bacterial peritonitis in adults.

Authors:  Mark Malota; Thomas W Felbinger; Reinhard Ruppert; Natascha C Nüssler
Journal:  Int J Surg Case Rep       Date:  2014-12-11

7.  Acute fatal group A Streptococcal primary peritonitis following vaginal delivery.

Authors:  Mohamed Aziz Daghmouri; Fatma Zahra Affes; Alia Jebri; Raja Boussassi; Sonia Ben Hamouda; Badreddine Bouguerra; Mohamed Houissa
Journal:  IDCases       Date:  2020-02-20

8.  M protein from Streptococcus pyogenes induces tissue factor expression and pro-coagulant activity in human monocytes.

Authors:  Lisa I Påhlman; Erik Malmström; Matthias Mörgelin; Heiko Herwald
Journal:  Microbiology (Reading)       Date:  2007-08       Impact factor: 2.777

9.  Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response.

Authors:  Fredrik Kahn; Matthias Mörgelin; Oonagh Shannon; Anna Norrby-Teglund; Heiko Herwald; Anders I Olin; Lars Björck
Journal:  PLoS Pathog       Date:  2008-09-12       Impact factor: 6.823

10.  Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2.

Authors:  Jiaqi Tang; Changjun Wang; Youjun Feng; Weizhong Yang; Huaidong Song; Zhihai Chen; Hongjie Yu; Xiuzhen Pan; Xiaojun Zhou; Huaru Wang; Bo Wu; Haili Wang; Huamei Zhao; Ying Lin; Jianhua Yue; Zhenqiang Wu; Xiaowei He; Feng Gao; Abdul Hamid Khan; Jian Wang; Guo-Ping Zhao; Yu Wang; Xiaoning Wang; Zhu Chen; George F Gao
Journal:  PLoS Med       Date:  2006-04-11       Impact factor: 11.069

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.